Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
暂无分享，去创建一个
F. Tubach | C. Louapre | S. Vukusic | E. Thouvenot | F. Sellal | D. Laplaud | J. Pelletier | P. Clavelou | D. Hajage | O. Heinzlef | D. Biotti | P. Labauge | J. de Seze | E. Maillart | H. Zéphir | C. Papeix | B. Bourre | C. Lebrun-Frénay | E. Berger | O. Casez | A. Maurousset | P. Branger | É. Manchon | Anne-Laure Dubessy | C. Bensa | L. Guilloton | Thibault Moreau | Edouard Januel